Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-28

FDA Approved: AVONEX — Supplemental Application (Biogen Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AVONEX (interferon beta-1a) from Biogen. The action updates the labeling or approved indications of the drug as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avonex (Interferon beta-1a)

Snippet

SUPPL AP for AVONEX (INTERFERON BETA-1A)